Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

5.15USD
11 Dec 2017
Change (% chg)

$-0.20 (-3.74%)
Prev Close
$5.35
Open
$5.35
Day's High
$5.35
Day's Low
$5.15
Volume
15,688
Avg. Vol
21,845
52-wk High
$9.80
52-wk Low
$4.20

Select another date:

Wed, Nov 15 2017

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results

BRIEF-Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma

* Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma Ltd as of Aug 31 - SEC filing Source text: (http://bit.ly/2gRgBs0) Further company coverage:

BRIEF-Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma

* Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing Source text : http://bit.ly/2vvPmop Further company coverage:

BRIEF-Intec Pharma announces pricing of $50 mln public offering of ordinary shares

* Intec Pharma announces pricing of $50.0 million public offering of ordinary shares

BRIEF-Intec Pharma announces proposed public offering of ordinary shares

* Intec Pharma announces proposed public offering of ordinary shares

BRIEF-Intec Pharma reports financial results for the first half of 2017​

* Intec Pharma reports financial results for the first six months of 2017

BRIEF-Intec Pharma reports clinical results from phase I trial of accordion pill for cannabinoid therapies

* Intec Pharma reports clinical results from phase i trial of accordion pill for cannabinoid therapies

BRIEF-Intec Pharma granted patent in Hong Kong for Accordion pill

* Intec Pharma Ltd says granted patent in Hong Kong for Accordion pill

BRIEF-Intec Pharma Ltd appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as CEO

* Intec Pharma Ltd - Intec Pharma appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as chief executive officer‍​

BRIEF-Intec Pharma appoints Jeffrey Meckler as CEO

* Intec Pharma appoints U.S. Life Sciences executive and vice chairman Jeffrey A. Meckler as chief executive officer

Select another date: